Trisalus Life Sciences, Inc.
Clinical trials sponsored by Trisalus Life Sciences, Inc., explained in plain language.
-
Liver cancer drug combo study halted early
Disease control TerminatedThis study tested a new drug called SD-101, given directly into the liver's blood supply, along with standard immunotherapy drugs, for people with two types of liver cancer (hepatocellular carcinoma and intrahepatic cholangiocarcinoma). The goal was to find a safe dose and see if…
Phase: PHASE1, PHASE2 • Sponsor: TriSalus Life Sciences, Inc. • Aim: Disease control
Last updated May 11, 2026 20:50 UTC
-
Experimental liver infusion for eye cancer shows early promise but trial halted
Disease control TerminatedThis study tested a new drug called SD-101, given directly into the liver using a special pressure device, alone or with standard immunotherapy, for adults with metastatic uveal melanoma that has spread to the liver. The goal was to find a safe dose and see if it could shrink tum…
Phase: PHASE1 • Sponsor: TriSalus Life Sciences, Inc. • Aim: Disease control
Last updated May 11, 2026 20:47 UTC